Lexicon Pharmaceuticals LXRX Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance.
The official record: Lexicon Pharmaceuticals’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?
- Lexicon Pharmaceuticals (LXRX) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount of $2.22M in Q4 2025.
- How has Lexicon Pharmaceuticals's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount changed year-over-year?
- Lexicon Pharmaceuticals's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount decreased by 71.2% year-over-year, from $7.69M to $2.22M.
- What is the long-term trend for Lexicon Pharmaceuticals's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount has grown at a -15.3% compound annual growth rate (CAGR), from $17.21M to $8.87M.
- What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount mean?
- The monetary adjustment to the valuation allowance for deferred tax assets, reflecting changes in the company's assessment of whether it is more likely than not that these assets will be realized. A significant increase often indicates management's conservative outlook on future taxable income.